RE: Handful Commercial Agreement by Christmas?5 Jan 2023 13:07
Silence deafening, Aug RNS stated all in place now for Voltz to commercialise Nano anti viral technology… and then this complete silence for now near 4 months..
Mark Duffin, CEO of nanosynth commented: "We are delighted by these extremely positive trial results and the important REACH UK registration which will allow our partner, Volz, to apply our antiviral technology to all of their products. This has the potential to lead to wider adoption by the global filtration industry. A pipeline of interest is already at an advanced stage, and we are hopeful that this will lead to considerable sales for our first to market antiviral product."